BIIB 241206 150.00C (BIIB241206C150000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BIIB241206C150000

Watchlist

13.39
-1.61-10.73%

15min DelayClose Dec 3 16:00 ET

13.48High11.34Low

Intraday

5D
Daily

News

Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Kevin Travers52minutes ago
Express News | Biogen Shares Down 2% at $160.80 in Volume Spike
Reuters15:59 ET
Biogen Inc. (BIIB) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript
Earnings Call Transcripts12:15 ET
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Kevin TraversDec 3 10:27 ET
Express News | Biogen Exec Says Co Expects "a Linear Trend" of About $10 Million in U.S. Sales per Quarter for Leqembi in the Near-Term - Conf Call
ReutersDec 3 09:44 ET
Palantir, MicroStrategy Lead List of Stocks That Could Join Nasdaq 100
BarronsDec 2 16:32 ET

Comments

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...

Movers and Shakers

Aug 1 07:27

Columns Today's Morning Movers and Top Ratings: META, ARM, MRNA, SHAK and More

Morning Movers
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...